Home-Based Phototherapy for Psoriasis Matches Office Efficacy With Better QOL
(MedPage Today) -- SAN DIEGO -- Home-based phototherapy for psoriasis achieved outcomes similar to office-based therapy, suggesting a potential for more convenient, less expensive treatment for some patients, according to a study reported here... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 11, 2024 Category: Dermatology Source Type: news
Sun Plus Certain Foods, Meds Can Bring on'Margarita Rashes '
MONDAY, March 11, 2024 -- Slicing some fresh limes for that margarita savored in the sun could be a bad combo for some people ' s skin, dermatologists warn.
Folks can break out in what are nicknamed " margarita rashes " if they are skin-sensitive to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 11, 2024 Category: General Medicine Source Type: news
Hidradenitis Suppurativa Responds Quickly to Novel BTK Inhibitor
(MedPage Today) -- SAN DIEGO -- An investigational Bruton's tyrosine kinase (BTK) inhibitor significantly improved hidradenitis suppurativa (HS) disease status in a randomized, placebo-controlled trial reported here.
More than 70% of patients... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 11, 2024 Category: Dermatology Source Type: news
Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis Control Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis Control
Both an approved anti-IL-17 therapy and an experimental oral anti-IL-23 therapy appeared to achieve relatively undiminished rates of psoriasis control in extension studies.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 11, 2024 Category: Dermatology Tags: Dermatology Source Type: news
Home- and Office-Based Phototherapy for Psoriasis Compared Home- and Office-Based Phototherapy for Psoriasis Compared
The multicenter LITE trial included 783 patients at 42 sites in the United States.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 10, 2024 Category: Consumer Health News Tags: Dermatology Source Type: news
During Pregnancy, Many Drugs Safe for Skin Infections During Pregnancy, Many Drugs Safe for Skin Infections
Several drugs should be avoided or used with caution because of potential risks during pregnancy, a dermatologist told colleagues.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 10, 2024 Category: Dermatology Tags: Dermatology Source Type: news
New NCCN Melanoma Guidelines Capture Evolving Best Practice New NCCN Melanoma Guidelines Capture Evolving Best Practice
NCCN guidelines for cutaneous melanoma, issued in February, capture evolving data for both diagnosis and treatment, diverging incrementally from 2019 AAD guidelines.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 9, 2024 Category: Internal Medicine Tags: Dermatology Source Type: news
Novel Drug Shows Promise for Hidradenitis Suppurativa Novel Drug Shows Promise for Hidradenitis Suppurativa
The findings suggest that Bruton ' s tyrosine kinase inhibition may emerge as a promising therapeutic intervention in HS.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 9, 2024 Category: Consumer Health News Tags: Dermatology Source Type: news
Flexibility Advised for Patients With Personality Disorders Flexibility Advised for Patients With Personality Disorders
Up to 15% of the general population is affected by a personality disorder, according to dermatologist, Mio Nakamura, MD.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 9, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news
Anti-DEI Petition Sparks Conflict at Nat'l Derm Meeting Anti-DEI Petition Sparks Conflict at Nat'l Derm Meeting
A controversial proposal to end the American Academy of Dermatology diversity programs will be considered at the group ' s annual meeting starting today.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 8, 2024 Category: Dermatology Tags: Dermatology Source Type: news
AAD: Concerns Noted Relating to Use of AI Dermatology Apps
FRIDAY, March 8, 2024 -- There are notable concerns relating to the use of currently available artificial intelligence (AI) dermatology mobile applications (apps), according to a study published online March 7 in JAMA Dermatology to coincide with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 8, 2024 Category: Pharmaceuticals Source Type: news
Aad 2024 aad 2024
Read clinically focused news coverage of key developments AAD 2024Medscape Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 8, 2024 Category: Consumer Health News Tags: None Conference Coverage Source Type: news
Sulfites Selected as ACDS Allergen of the Year Sulfites Selected as ACDS Allergen of the Year
Experts lobby for increased inclusion of sulfites in patch test panels.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 8, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news
Psoriasis Study Shows a Path for Considering US Drug Costs Psoriasis Study Shows a Path for Considering US Drug Costs
Only three of 13 psoriasis biologics appeared to be cost-effective based on US prices in a new analysis. The finding may aid policymakers struggling with drug price negotiations.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 8, 2024 Category: Dermatology Tags: Dermatology Source Type: news
July 19, 2016: Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement - 07/18/2016
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
